Carbylan Therapeutics (CBYL) Priced

Developing a novel, injectable treatment for osteoarthritis pain in the knee.

Health Care - Biotechnology

IPO Performance
Latest Trade $0.68 +0.01 (+1.8%)
First Day Return 11.2%
Return from IPO -86.7%
 
Carbylan Therapeutics IPO News more
  • .
IPO Data
IPO File Date 12/29/2014
Offer Price $5.00
Price Range $5.00 - $5.00
Offer Shares (mm) 13.0
Deal Size ($mm) 65
 
IPO Data
IPO Date 04/08/2015
Offer Price $5.00
Price Range $5.00 - $5.00
Offer Shares (mm) 13.0
Deal Size ($mm) $65
 
Underwriters
more
Business Overview
Developing a novel, injectable treatment for osteoarthritis pain in the knee.
Developing a novel, injectable treatment for osteoarthritis pain in the knee.
more
Company Data
Headquarters Palo Alto, CA
Founded 2004
Employees 14
Website www.carbylan.com
 

Performance vs. IPO Index (IPOUSA)